Sanofi India · NSE: SANOFI · BSE: 500674
Q3 FY23 results · Oct–Dec 2022
Sanofi India reported revenue from operations of ₹671.90 crore (down 2.3% from Q3 FY22) and net profit of ₹130.90 crore (up 44.8% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a standalone basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 671.90 | 687.90 | −2.3% | 691.90 | −2.9% |
| Other income | 20.00 | 16.30 | +22.7% | 11.40 | +75.4% |
| Total income | 691.90 | 704.20 | −1.7% | 703.30 | −1.6% |
| Profit before tax | 190.40 | 132.20 | +44.0% | 182.40 | +4.4% |
| Net profit for the period | 130.90 | 90.40 | +44.8% | 130.90 | +0.0% |
| EPS, basic (₹) | 56.84 | 39.25 | +44.8% | 56.84 | +0.0% |
| Net margin (%) | 19.5 | 13.1 | 18.9 |
Standalone
- Filed with BSE
- 27 Feb 2023, 10:14 IST
- Board meeting
- 23 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE